Evidence map›Paper›PMID 40336974›Full record

ArticlePrecision radiation oncology2024

Clinical results of definitive radiotherapy for local recurrent kimura disease in the head and neck after surgery: A retrospective study.

Wenlong Lv, Shan Li, Feng Liu, Wangui Xue, Feibao Guo, Jinsheng Hong

Abstract read
In one paragraph

Article in Precision radiation oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Low-dose radiotherapy as a definitive treatment for Kimura's disease.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wenlong LvDepartment of Radiotherapy Cancer Center The First Affiliated Hospital of Fujian Medical University Fuzhou China.ORCID https://orcid.org/0009-0005-4995-7684
Shan LiDepartment of Radiotherapy Cancer Center The First Affiliated Hospital of Fujian Medical University Fuzhou China.
Feng LiuDepartment of Radiotherapy Cancer Center The First Affiliated Hospital of Fujian Medical University Fuzhou China.
Wangui XueDepartment of Radiotherapy Cancer Center The First Affiliated Hospital of Fujian Medical University Fuzhou China.
Feibao GuoDepartment of Radiotherapy Cancer Center The First Affiliated Hospital of Fujian Medical University Fuzhou China.
Jinsheng HongDepartment of Radiotherapy Cancer Center The First Affiliated Hospital of Fujian Medical University Fuzhou China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the efficacy and safety of definitive radiotherapy in selected patients with local recurrence of Kimura disease of the head and neck after surgery. Methods: This retrospective study collected the clinical data of 14 patients with postoperative recurrence of Kimura disease of the head and neck who received definitive radiotherapy at the First Affiliated Hospital of Fujian Medical University between 2006 and 2022. The radiation dose ranged from 28 to 40 Gy. Its efficacy and safety were analyzed. Results: During follow-up, ranging from 17 to 168 months, local control was achieved in 13 (92.9%) of the 14 patients with postoperative recurrence. There were no serious late toxicities except for mild xerostomia in four (28.6%) patients; the patients' peripheral blood eosinophil count dropped from 1.73×10 Conclusions: The findings of the study suggest that definitive radiotherapy is a viable and effective alternative to repeated surgery for managing recurrent Kimura disease of the head and neck, with significant response rates and a good safety profile. Peripheral blood eosinophil counts and percentages serve as simple and reliable biomarkers for monitoring Kimura disease progression and treatment responses.

Indexed as

head and neckKimura diseaseradiotherapytumor recurrence

Identifiers

PMID40336974
PMCPMC11935113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.